-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 20, the NMPA official website showed that the lidocaine hydrochloride injection of Shiyao Yinhu Pharmaceutical passed the consistency evaluation of generic drugs
Lidocaine hydrochloride injection is mainly used for infiltration anesthesia, epidural anesthesia, topical anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block; it can be used for ventricular premature beats and ventricular contractions after acute myocardial infarction It can also be used for ventricular arrhythmia caused by digitalis poisoning, cardiac surgery and cardiac catheterization
According to data from Minet.
Sales of lidocaine hydrochloride injection (unit: ten thousand yuan)
Source: Minet.
With the over-evaluation of Lidocaine Hydrochloride Injection of CSPC Yinhu Pharmaceutical, there are currently 7 companies that have over-reviewed the product, including Kelun Pharmaceutical, Shandong Hualu Pharmaceutical, Shanghai Hefeng Pharmaceutical, Tianjin Jinyao Pharmaceutical, etc.
CSPC passed/deemed to pass the consistency evaluation varieties
Note: Mark * is the first review, ** is the exclusive review
Up to now, CSPC has passed/deemed to pass the consistency evaluation of 68 varieties (104 product specifications), of which 21 varieties are the first to pass the evaluation
Data source: Minet database, NMPA